Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...
Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of ...
Research: A Fulgent lab technician uses a multichannel pipette to dispense a reagent. El Monte-based genetic testing and clinical lab analysis company Fulgent Genetics Inc., which rode the Covid ...
Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US-based laboratories, for a combined purchase price of around $55.5m.
Fulgent Genetics will acquire assets from Bako Diagnostics and StrataDx for $55.5 million in a deal that will expand the company's offering of testing services. Bako provides specialty laboratory ...
TRUMBULL, Conn. and EL MONTE, Calif., Feb. 9, 2024 /PRNewswire/ -- CooperSurgical ®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (FLGT), a technology-based company ...
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development ...
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base Fulgent Genetics continues to build upon its laboratory services platform both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback